Losartan and Hydrochlorothiazide Tablets Market

Losartan/hydrochlorothiazideis a combination of two drugs in a single form. It's used to treat high blood pressure. It's also used to reduce the risk of stroke in people with high blood pressure and a heart condition called left ventricular hypertrophy.

Losartan and Hydrochlorothiazide Tablets Market contains market size and forecasts of Losartan and Hydrochlorothiazide Tablets in global, including the following market information:

Global Losartan and Hydrochlorothiazide Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Losartan and Hydrochlorothiazide Tablets Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Losartan and Hydrochlorothiazide Tablets companies in 2021 (%)

The global Losartan and Hydrochlorothiazide Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

50 mg/ 12.5 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Losartan and Hydrochlorothiazide Tablets include Alembic, Cadista, Lupin, Rising Pharmaceuticals, Sandoz, Teva, Merck, Torrent and Aurobindo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Losartan and Hydrochlorothiazide Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Losartan and Hydrochlorothiazide Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Losartan and Hydrochlorothiazide Tablets Market Segment Percentages, by Type, 2021 (%)

• 50 mg/ 12.5 mg
• 100 mg/ 25 mg

Global Losartan and Hydrochlorothiazide Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Losartan and Hydrochlorothiazide Tablets Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Losartan and Hydrochlorothiazide Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Losartan and Hydrochlorothiazide Tablets Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Losartan and Hydrochlorothiazide Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Losartan and Hydrochlorothiazide Tablets revenues share in global market, 2021 (%)
• Key companies Losartan and Hydrochlorothiazide Tablets sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Losartan and Hydrochlorothiazide Tablets sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Alembic
• Cadista
• Lupin
• Rising Pharmaceuticals
• Sandoz
• Teva
• Merck
• Torrent
• Aurobindo